Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
eli lilly
3
×
fda
3
×
indiana blog main
indiana top stories
life sciences
national blog main
raleigh-durham blog main
raleigh-durham top stories
amgen
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
deals
detroit blog main
detroit top stories
generic drugs
ipo
lasmiditan
national
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
shire
startups
takeda pharmaceutical
teva pharmaceutical
texas blog main
texas top stories
triptans
wisconsin blog main
What
pharmaceutical
3
×
bio
drugs
eli
giant
new
roundup
acute
addresses
appetite
approval
bails
black
brand
bread
bridgebio
butter
buyout
cancer
capital
car
cash
causes
condition
decades
develop
diabetes
diamond’s
drug
emerges
fda
firm
friday
giving
grab
grabbed
hasn’t
headlines
hold
ichnos
Language
unset
Current search:
pharmaceutical
×
fda
×
" eli lilly "
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More